CVS vs HQY
CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences. HQY: HealthEquity is the largest HSA administrator by account count, managing $36.5 billion in consumer healthcare savings through technology-enabled services integrated with the broader health and benefits ecosystem.
Side-by-side fundamentals
| Metric | CVS | HQY | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $106.89 | $94.33 | |
| Market cap as of 2026-07-24 | $136.2B | $8.0B | |
| P/E as of 2026-07-24 | 46.45 | 34.77 | HQY lower |
| PEG as of 2026-07-24 | 3.33 | 1.65 | HQY lower |
| Net margin as of 2026-07-24 | +0.7% | +17.3% | HQY higher |
| Gross margin as of 2026-07-24 | +13.9% | +70.7% | HQY higher |
| Operating margin as of 2026-07-24 | +1.6% | +25.6% | HQY higher |
| ROE as of 2026-07-24 | +3.9% | +10.9% | HQY higher |
| ROA as of 2026-07-24 | +1.1% | +6.8% | HQY higher |
| Debt / equity as of 2026-07-24 | 0.81 | 0.46 | HQY lower |
| Revenue growth (YoY) as of 2026-07-24 | +7.6% | +7.6% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +15.1% | HQY higher |
| Dividend yield as of 2026-07-24 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-24 | 0.59 | 0.24 | |
| 1-year return as of 2026-07-23 close | +72.8% | -1.5% | CVS higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.